X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
female (14) 14
index medicus (14) 14
middle aged (13) 13
oncology (13) 13
adult (12) 12
pathology (11) 11
aged (10) 10
chemotherapy (9) 9
immunohistochemistry (8) 8
male (8) 8
breast cancer (7) 7
cancer (7) 7
metastasis (7) 7
prognosis (7) 7
gene expression (6) 6
medicine (6) 6
research (6) 6
research article (6) 6
tumors (6) 6
aged, 80 and over (5) 5
antineoplastic agents - pharmacology (5) 5
breast neoplasms - metabolism (5) 5
cancer patients (5) 5
cell line, tumor (5) 5
clinical trials (5) 5
endocrinology & metabolism (5) 5
erbb-2 protein (5) 5
genetic aspects (5) 5
hospitals (5) 5
medical research (5) 5
multidisciplinary sciences (5) 5
multivariate analysis (5) 5
patients (5) 5
receptor, erbb-2 - metabolism (5) 5
rna, messenger - genetics (5) 5
science (5) 5
activation (4) 4
analysis (4) 4
biomarkers (4) 4
biomarkers, tumor - metabolism (4) 4
breast neoplasms - pathology (4) 4
cancer research (4) 4
cancer therapies (4) 4
metastases (4) 4
neoplasm metastasis (4) 4
patient outcomes (4) 4
proteins (4) 4
rna, messenger - metabolism (4) 4
studies (4) 4
survival (4) 4
tumor-cells (4) 4
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - therapeutic use (3) 3
apoptosis - drug effects (3) 3
biomarkers, tumor - genetics (3) 3
breast (3) 3
breast neoplasms - drug therapy (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - mortality (3) 3
carcinoma - genetics (3) 3
care and treatment (3) 3
cohort studies (3) 3
dacarbazine - analogs & derivatives (3) 3
disease-free survival (3) 3
egfr (3) 3
estrogen-receptor (3) 3
gene amplification (3) 3
gene expression profiling (3) 3
gene expression regulation, neoplastic (3) 3
gene-expression (3) 3
genetics (3) 3
immunology (3) 3
in-vivo (3) 3
inhibitor (3) 3
insulin-like growth factor i - pharmacology (3) 3
laboratories (3) 3
medical colleges (3) 3
medicine & public health (3) 3
medicine, experimental (3) 3
messenger-rna expression (3) 3
mutation (3) 3
neoplasms (3) 3
oncology, experimental (3) 3
paraffin (3) 3
pathology and forensic medicine (3) 3
phosphorylation (3) 3
polymerase chain reaction (3) 3
receptor, erbb-2 - genetics (3) 3
retrospective studies (3) 3
risk factors (3) 3
rna (3) 3
skin and connective tissue diseases (3) 3
thyroid neoplasms - drug therapy (3) 3
thyroid neoplasms - pathology (3) 3
trastuzumab (3) 3
treatment outcome (3) 3
adenocarcinoma (2) 2
adjuvant temozolomide (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 8, pp. 753 - 762
Journal Article
Virchows Archiv, ISSN 0945-6317, 2/2013, Volume 462, Issue 2, pp. 141 - 154
Journal Article
BMC Cancer, ISSN 1471-2407, 01/2012, Volume 12, Issue 1, pp. 3 - 3
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2009, Volume 4, Issue 11, p. e7746
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2018, Volume 13, Issue 12, p. e0207707
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, p. e99131
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e70634
Background: Discrepant data have been published on the incidence and prognostic significance of ESR1 gene amplification in early breast cancer. Patients and... 
SYSTEM | TRIALS | CLINICAL-ONCOLOGY/COLLEGE | THERAPY | MULTIDISCIPLINARY SCIENCES | IN-SITU HYBRIDIZATION | ESTROGEN-RECEPTOR | AMERICAN-SOCIETY | CHEMOTHERAPY | PATHOLOGISTS GUIDELINE RECOMMENDATIONS | Immunohistochemistry | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Gene Expression Profiling | RNA, Messenger - metabolism | Biomarkers, Tumor | Breast Neoplasms - metabolism | Young Adult | Adult | Estrogen Receptor alpha - metabolism | Female | RNA, Messenger - genetics | In Situ Hybridization, Fluorescence | Gene Dosage | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Gene Amplification | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | Neoplasm Staging | Messenger RNA | Oncology, Experimental | Genes | Cytogenetics | Breast cancer | Genetic aspects | Research | Risk factors | Cancer | Adenocarcinoma | Laboratories | Copy number | Clinical trials | Fluorescence | Oncology | Fluorescent indicators | Paraffin | Gene deletion | Proteins | ESR1 protein | Clonal deletion | Fluorescence in situ hybridization | Paclitaxel | Deletion | Medical research | Risk groups | DNA probes | Health risks | Gene expression | Patients | ErbB-2 protein | Medicine | Studies | Amplification | Pathology | Gene amplification | Hospitals | Ribonucleic acids | Breast | Protein expression | Gain | Tumors
Journal Article